Since RhoGDI2 promotes gastric cancer cell invasion21 as well as enhances cisplatin resistance, we next examined whether the restoration of 14-3-3σ could alter the migration and invasive properties in RhoGDI2-overexpressing gastric cancer cells. This evidence concerns the gene ARHGDIB and gastric cancer.